Non-Profit Trusted Source of Non-Commercial Health Information
The Original Voice of the American Academy of Anti-Aging, Preventative, and Regenerative Medicine
logo logo
Neurology Brain and Mental Performance

Brain Disease Gene

5 years, 11 months ago

12214  0
Posted on May 24, 2018, 1 a.m.

Ankrd16 gene has been identified to help prevent buildup of harmful aggregate protein deposits which can lead to neurological disorders including Parkinson’s and Alzheimer’s disease. The gene functions as a failsafe in proofreading and correcting errors to help avoid production of abnormal improper proteins, as published in the journal Nature.

Typically the transfer if information from gene to protein is carefully controlled being biologically proofread and corrected for errors to avoid production of improper proteins. Ankrd16 protein has been observed to rescue specific Purkinje cell neurons which die when proofreading fails. Those nerve cells in the cerebellum incorrectly activate amino acid serine which is improperly incorporated into proteins and causes aggregation without normal levels of Ankrd16 proteins.

 

Ankrd16 acts as a layer of machinery key to prevention of severe pathologies arising from defects via acting as a safety sponge capturing incorrectly activated serine as a failsafe to prevent the amino acid from being incorporated into proteins improperly, which is helpful when the ability of the nerve cells to proofread and correct mistakes declines.

 

Ankrd16 levels as normally low in Purkinje cells making them vulnerable to defects, elevating Ankrd16 levels protects the cells from dying. Removing Ankrd16 from other neurons in model mice with proofreading deficiency was observed to cause widespread buildup of abnormal proteins leading to neuronal death.

 

Researchers noted that few modifier genes of mutations have been identified such as Ankrd16 with a modifier based mechanism for understanding underlying pathology of neurodegenerative diseases which show promise of one day being route to understanding disease development and development of therapies.

Materials provided by University of California - San Diego.

Note: Content may be edited for style and length.

 

Journal Reference:

My-Nuong Vo, Markus Terrey, Jeong Woong Lee, Bappaditya Roy, James J. Moresco, Litao Sun, Hongjun Fu, Qi Liu, Thomas G. Weber, John R. Yates, Kurt Fredrick, Paul Schimmel, Susan L. Ackerman. ANKRD16 prevents neuron loss caused by an editing-defective tRNA synthetase. Nature, 2018; DOI: 10.1038/s41586-018-0137-8

 

WorldHealth Videos